Additionally, certain inflammatory mediators, such as IL-17, TNF-α, and CXCL8, are significantly increased in COPD patients, participating in inflammatory responses and tissue destruction through various signaling pathways (18–22). The gene discussed is IL17A; the disease is chronic obstructive pulmonary disease.